CHERYL ALEMAN: Open Payments
NPI 1740905751 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,951 in 108 payments from 20 companies in 2025. Trend: 2023 $780 · 2024 $982 · 2025 $1,951
Food & beverage: $1,851Education: $100
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 41 | $463 |
| AstraZeneca Pharmaceuticals LP | 19 | $391 |
| Axsome Therapeutics, Inc. | 6 | $169 |
| Astellas Pharma US Inc | 4 | $164 |
| PFIZER INC. | 7 | $143 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $127 |
| ABBVIE INC. | 3 | $69 |
| Philips North America LLC | 3 | $69 |
| Exact Sciences Corporation | 2 | $49 |
| SHIELD THERAPEUTICS INC | 2 | $46 |
Products named: OTEZLA, Auvelity, FARXIGA, BREZTRI, REPATHA, XIFAXAN, NURTEC ODT, Vest Therapy Und.
Industry payments across CA — which companies pay providers there.
